Brief: Anika Therapeutics Q4 revenue USD 39.622 million

Anika Therapeutics

06/03/2023 21:05

Mar 6 (Reuters) - Anika Therapeutics Q4 net income USD -4.908 million.
* Q4 revenue USD 39.622 million
* Q4 pretax profit USD -6.391 million
* Q4 gross profit USD 24.131 million
* Q4 income from operations USD -6.667 million